Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Ann Denise Thor

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Thor, Ann

One or more keywords matched the following items that are connected to Thor, Ann

Item Type	Name
Academic Article	Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Academic Article	Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay.
Academic Article	Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism.
Academic Article	Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
Academic Article	The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
Academic Article	Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Academic Article	Altered expression of the DNA repair protein, N-methylpurine-DNA glycosylase (MPG) in breast cancer.
Academic Article	c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
Academic Article	HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.
Academic Article	pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.
Academic Article	Ets regulation of the erbB2 promoter.
Academic Article	Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.
Academic Article	Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.
Academic Article	erbB-2 (HER-2) and breast cancer progression.
Academic Article	erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.
Academic Article	Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
Academic Article	Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.
Academic Article	Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
Academic Article	Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit.
Academic Article	Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Academic Article	pS2 expression and response to hormonal therapy in patients with advanced breast cancer.
Academic Article	Caspase expression profile and functional activity in a panel of breast cancer cell lines.
Academic Article	Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
Academic Article	HER2 and response to paclitaxel in node-positive breast cancer.
Academic Article	Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
Academic Article	The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.
Academic Article	Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
Academic Article	Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
Academic Article	Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin.
Academic Article	Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.
Academic Article	Invasive micropapillary carcinoma of the breast: a prognostic study.
Academic Article	Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
Academic Article	Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.
Academic Article	p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcome.
Academic Article	HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.
Academic Article	Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer.
Academic Article	Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions.
Academic Article	Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer.
Academic Article	Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
Academic Article	Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Academic Article	Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Academic Article	Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
Academic Article	Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
Academic Article	Perinucleolar compartment prevalence has an independent prognostic value for breast cancer.
Academic Article	Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy.
Academic Article	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Academic Article	Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients.
Academic Article	Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Academic Article	Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.
Academic Article	Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.
Academic Article	p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).
Academic Article	Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications.
Concept	Breast Neoplasms
Academic Article	Glucose promotes breast cancer aggression and reduces metformin efficacy.
Academic Article	Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
Academic Article	Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.
Academic Article	Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Academic Article	Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling.
Academic Article	Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.
Academic Article	Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Academic Article	Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).
Academic Article	The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells.
Academic Article	Metformin attenuates transforming growth factor beta (TGF-?) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Academic Article	Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
Grant	E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE
Academic Article	The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.
Academic Article	Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells.
Academic Article	Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Academic Article	Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
Academic Article	Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer.
Academic Article	Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.
Academic Article	FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Concept	Triple Negative Breast Neoplasms
Academic Article	Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers.
Academic Article	Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem.
Academic Article	Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer.
Academic Article	Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer.
Academic Article	HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel.

Search Criteria

Breast Neoplasms